193 related articles for article (PubMed ID: 35436882)
1. Dysregulation of Wnt signaling in bone of type 2 diabetes mellitus and diabetic Charcot arthropathy.
Gassel LC; Schneider S; Banke IJ; Braun KF; Volkering C; Zeeb L; Burgkart RHH; von Eisenhart-Rothe R; Biberthaler P; van Griensven M; Haug AT
BMC Musculoskelet Disord; 2022 Apr; 23(1):365. PubMed ID: 35436882
[TBL] [Abstract][Full Text] [Related]
2. Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients.
Folestad A; Ålund M; Asteberg S; Fowelin J; Aurell Y; Göthlin J; Cassuto J
Acta Orthop; 2015; 86(4):415-25. PubMed ID: 25811776
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of bone fragility by pulsed electromagnetic fields in type 2 diabetic KK-Ay mice involving Wnt/β-catenin signaling.
Shao X; Yang Y; Tan Z; Ding Y; Luo E; Jing D; Cai J
Am J Physiol Endocrinol Metab; 2021 May; 320(5):E951-E966. PubMed ID: 33719588
[TBL] [Abstract][Full Text] [Related]
4. Bone Mineral Density in Type 2 Diabetes Patients with Charcot Arthropathy.
El Oraby HA; Abdelsalam MM; Eid YM; El Hilaly R; Marzouk HA
Curr Diabetes Rev; 2019; 15(5):395-401. PubMed ID: 29992889
[TBL] [Abstract][Full Text] [Related]
5. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling.
Wu Y; Xu SY; Liu SY; Xu L; Deng SY; He YB; Xian SC; Liu YH; Ni GX
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):470-478. PubMed ID: 28239825
[TBL] [Abstract][Full Text] [Related]
6. Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density.
Herbst SA; Jones KB; Saltzman CL
J Bone Joint Surg Br; 2004 Apr; 86(3):378-83. PubMed ID: 15125125
[TBL] [Abstract][Full Text] [Related]
7. Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes.
Petrova NL; Foster AV; Edmonds ME
Diabet Med; 2005 Jun; 22(6):756-61. PubMed ID: 15910628
[TBL] [Abstract][Full Text] [Related]
8. Acute Charcot arthropathy successfully treated with pamidronate: long-term follow-up.
Naqvi A; Cuchacovich R; Saketkoo L; Espinoza LR
Am J Med Sci; 2008 Feb; 335(2):145-8. PubMed ID: 18277124
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density and markers of bone turnover and inflammation in diabetes patients with or without a Charcot foot: An 8.5-year prospective case-control study.
Jansen RB; Christensen TM; Bülow J; Rørdam L; Holstein PE; Jørgensen NR; Svendsen OL
J Diabetes Complications; 2018 Feb; 32(2):164-170. PubMed ID: 29196119
[TBL] [Abstract][Full Text] [Related]
10. Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher advanced glycation end-products (AGEs) content and reduced bone strength.
Leanza G; Cannata F; Faraj M; Pedone C; Viola V; Tramontana F; Pellegrini N; Vadalà G; Piccoli A; Strollo R; Zalfa F; Beeve AT; Scheller EL; Tang SY; Civitelli R; Maccarrone M; Papalia R; Napoli N
Elife; 2024 Apr; 12():. PubMed ID: 38598270
[TBL] [Abstract][Full Text] [Related]
11. Mortality and complications after treatment of acute diabetic Charcot foot.
Jansen RB; Jørgensen B; Holstein PE; Møller KK; Svendsen OL
J Diabetes Complications; 2018 Dec; 32(12):1141-1147. PubMed ID: 30301593
[TBL] [Abstract][Full Text] [Related]
12. MDCT assessment of CAD in type-2 diabetic subjects with diabetic neuropathy: the role of Charcot neuro-arthropathy.
Marano R; Pitocco D; Di Stasio E; Savino G; Merlino B; Trani C; Pirro F; Rutigliano C; Santangelo C; Minoiu AC; Natale L; Bonomo L
Eur Radiol; 2016 Mar; 26(3):788-96. PubMed ID: 26139314
[TBL] [Abstract][Full Text] [Related]
13. Diabetic charcot neuroarthropathy of the hand: clinical course, diagnosis, and treatment options.
Illgner U; van Netten J; Droste C; Meiners T; Postema K; Wetz HH
Diabetes Care; 2014; 37(5):e91-2. PubMed ID: 24757250
[No Abstract] [Full Text] [Related]
14. Role of Wnt signaling pathways in type 2 diabetes mellitus.
Chen J; Ning C; Mu J; Li D; Ma Y; Meng X
Mol Cell Biochem; 2021 May; 476(5):2219-2232. PubMed ID: 33566231
[TBL] [Abstract][Full Text] [Related]
15. Charcot arthropathy of the diabetic foot in a sub-Saharan tertiary hospital: a cross-sectional study.
Wanzou JPV; Sekimpi P; Komagum JO; Nakwagala F; Mwaka ES
J Foot Ankle Res; 2019; 12():33. PubMed ID: 31210786
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of Dickkopf-1 are indicative of Wnt/β-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density.
Tsentidis C; Gourgiotis D; Kossiva L; Marmarinos A; Doulgeraki A; Karavanaki K
Osteoporos Int; 2017 Mar; 28(3):945-953. PubMed ID: 27766367
[TBL] [Abstract][Full Text] [Related]
17. Loss of RAGE defense: a cause of Charcot neuroarthropathy?
Witzke KA; Vinik AI; Grant LM; Grant WP; Parson HK; Pittenger GL; Burcus N
Diabetes Care; 2011 Jul; 34(7):1617-21. PubMed ID: 21593297
[TBL] [Abstract][Full Text] [Related]
18. Arthrodesis as an early alternative to nonoperative management of charcot arthropathy of the diabetic foot.
Simon SR; Tejwani SG; Wilson DL; Santner TJ; Denniston NL
J Bone Joint Surg Am; 2000 Jul; 82-A(7):939-50. PubMed ID: 10901308
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus.
Rizzo P; Pitocco D; Zaccardi F; Di Stasio E; Strollo R; Rizzi A; Scavone G; Costantini F; Galli M; Tinelli G; Flex A; Caputo S; Pozzilli P; Landolfi R; Ghirlanda G; Nissim A
Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27454862
[TBL] [Abstract][Full Text] [Related]
20. Cementless total ankle arthroplasty in diabetic neuropathic arthropathy.
Lee KB; Cho SG; Seon JK
Diabet Med; 2008 Nov; 25(11):1358-60. PubMed ID: 19046229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
